Financial report interval: 2024.12.31 - 2025.12.31
Preview: PEGBIO CO-B(02565) predict that the Revenue is 0 (--%), Meet estimate;the EBIT is -228.82 M (--%), Miss estimate;the EPS is -0.626 (+25.05%), Miss estimate.